T Cell Stimulation via CD47: Agonistic and Antagonistic Effects of CD47 Monoclonal Antibody 1/1A4

Journal of Immunology

Volumn 159, Issue 11, 1997, Pages 5345-5354

  Waclavicek, Martina ^a   Majdic, Otto ^a   Stulnig, Thomas ^a   Berger, Markus ^a   Baumruker, Thomas ^b   Knapp, Walter ^a   Pickl, Winfried F ^a,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NOVARTIS RESEARCH INSTITUTE   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CARRIER PROTEIN; CD28 ANTIGEN; CD3 ANTIGEN; CD47 ANTIGEN; CD47 PROTEIN, HUMAN; INTERLEUKIN 1; INTERLEUKIN 6; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY;

ARTICLE; CELL CULTURE; HUMAN; IMMUNOLOGY; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; MIXED LYMPHOCYTE CULTURE; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, CD47; CALCIUM; CARRIER PROTEINS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; JURKAT CELLS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0031296853     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Bretscher, P., and M. Cohn. 1970. A theory of self-nonself discrimination. Science 169:1042.
2. Mueller, D. L., M. K. Jenkins, and R. H. Schwartz. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 1989:445.
3. Schwartz, R. H. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248:1349.
4. Steinman, R. M., and J. W. Young. 1991. Signals arising from antigen-presenting cells. Curr. Opin. Immunol. 3:361.
5. Janeway, C. A. 1992. The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu. Rev Immunol. 10:645.
6. Emmrich F., L. Kanz, and K. Eichmann. 1987. Cross-linking of the T cell receptor complex with the subset-specific differentiation antigen stimulates interleukin 2 receptor expression in human CD4 and CD8 T cells. Eur. J. Immunol. 17:529.
7. Freeman, G. J., J. G. Gribben, V. A. Boussiotis, J. W. Ng, V. Restivo, L. Lombard, G. S. Gray, and L. M. Nadler. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262:909.
8. Linsley, P. S., W. Brady, L. Grosmaire, A. Aruffo, N. K. Damle, and J. R. Ledbetter. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:721.
9. Grewal, I. S., J. Xu, and R. A. Flavell. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378:617.
10. Notarangelo, L. D., M. Duse, and A. G. Ugazio. 1992. Immunodeficiency with hyper-IgM (HIM). Immunodefic. Rev. 3:101.
11. van Lier, R. A. W., M. Brouwer, and L. A. Aarden. 1988. Signals involved in T cell activation. T cell proliferation induced through the synergistic action of anti-CD28 and anti-CD2 monoclonal antibodies. Eur. J. Immunol. 18:167.
12. Ledbetter, J. A., P. J. Martin, C. E. Spooner, D. Wofsy, T. T. Tsu, P. G. Beatty, and P. Gladstone. 1985. Antibodies to Tp67 and Tp44 augment and sustain proliferative responses of activated T cells. J. Immunol. 135:2331.
13. Verwilghen, J., P. Vandenberghe, G. Wallays, M. de Boer, N. Anthony, G. Panayi, and J. L. Ceuppens. 1993. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor occupancy. J. Immunol. 150:835.
14. Meuer, S. C., R. Hussey, M. Fabbi, D. Fox, O. Acuto, K. A. Fitzgerald, J. C. Hodgdon, J. P. Protentis, S. F. Schlossman, and E. L. Reinherz. 1984. An alternative pathway of T cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell 36:897.
15. ++ levels. J. Exp. Med. 163:654.
16. Holter, W., M. Schwarz, A. Cerwenka, and W. Knapp. 1996. The role of CD2 as a regulator of human T cell cytokine production. Immunol. Rev. 153:107.
17. Hünig, T., G. Tiefenthaler, K.-H. Mayer zum Büschenfelde, and S. C. Meuer. 1987. Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand. Nature 326:298.
18. Ceuppens, J. L., and M. L. Baroja. 1986. Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3. J. Immunol. 137:1816.
19. Carrera, A. C., M. Rincón, F. Sánchez-Madrid, M. López-Botet, and M. O. de Landázuri. 1988. Triggering of co-mitogenic signals in T cell proliferation by anti-LFA-1 (CD18, CD11a), LFA-3, and CD7 monoclonal antibodies. J. Immunol. 141:1919.
20. van Noesel, C., F. Miedema, M. Brouwer, M. A. de Rie, L. A. Aarden, and R. A. van Lier. 1988. Regulatory properties of LFA-1 α and β chains in human T-lymphocyte activation. Nature 333:850.
21. Dang, N. H., Y. Torimoto, K. Deusch, S. F. Schlossman, and C. Morimoto. 1990. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways. J. Immunol. 144:4092.
22. van Lier, R. A. W., J. Borst, T. M. Vroom, H. Klein, P. van Mourik, W. P. Zeijlemaker, and C. J. M. Melief. 1987. Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J. Immunol. 139:1589.
23. Sunder-Plassmann, R., W. F. Pickl, O. Majdic, W. Knapp, and W. Holter. 1995. Crosslinking of CD27 in the presence of CD28 costimulation results in T cell proliferation and cytokine production. Cell. Immunol. 164:20.
24. Rowan, W. C., G. Hale, J. P. Tite, and S. J. Brett. 1994. Cross-linking of the CAMPATH-1 antigen (CD52) triggers activation of normal human T lymphocytes. Int. Immunol. 7:69.
25. Cebrián, M., E. Yagüe, M. Rincón, M. López-Botet, M. O. de Landázuri, and F. Sánchez-Madrid. 1988. Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J. Exp. Med. 168:1621.
26. Geppert, T. C., M. C. Wacholtz, L. S. Davis, and P. E. Lipsky. 1988. Activation of human T4 cells by cross-linking class I MHC molecules. J. Immunol. 140: 2155.
27. Schwarz, M., J. Bohuslav, O. Majdic, H. Stockinger, W. Knapp, and W. Holter. 1995. Identification of the TS2/18-recognized epitope on the CD2 molecule as a target for suppression of T cell cytokine synthesis. J. Immunol. 154:5813.
28. + T lymphocytes by human blood dendritic cells in vitro. J. Clin. Invest. 90:229.
29. Verwilghen, J., G. H. Kingsley, J. L. Ceuppens, and G. S. Panayi. 1992. Inhibition of synovial fluid T cell proliferation by anti-CD5 monoclonal antibodies: a potential mechanism for their immunotherapeutic action in vivo. Arthritis Rheum. 35:1445.
30. Costantinides, Y., G. Kingsley, C. Pitzalis, and G. S. Panayi. 1991. Inhibition of lymphocyte proliferation by a monoclonal antibody (RFT2) against CD7. Clin. Exp. Immunol. 85:164.
31. Akbar, A. N., P. L. Amlot, K. Ivory, A. Timms, and G. Janossy. 1990. Inhibition of alloresponsive naive and memory T cells by CD7 and CD25 antibodies and by cyclosporine. Transplantation 50:823.
32. Schön, E., S. Jahn, S. T. Kiessig, H. U. Demuth, K. Neubert, A. Barth, R. Von Baehr, and S. Ansorge. 1987. The role of dipeptidyl peptidase IV in human T lymphocyte activation: inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro. Eur. J. Immunol. 17:1821.
33. Wrenger, S., D. Reinhold, T. Hoffmann, M. Kraft, R. Frank, J. Faust, K. Neubert, and S. Ansorge. 1996. The N-terminal X-X-Pro sequence of the HIV-1 Tat protein is important for the inhibition of dipeptidyl peptidase IV (DP IV/CD26) and the suppression of mitogen-induced proliferation of human T cells. FEBS Lett. 383:145.
34. Sugita, K., Y. Torimoto, Y. Nojima, J. F. Daley, S. F. Schlossman, and C. Morimoto. 1991. The 1A4 molecule (CD27) is involved in T cell activation. J. Immunol. 147:1477.
35. 3-dependent ligand binding. J. Cell Biol. 123:485.
36. Mawby, W., C. H. Holmes, D. J. Anstee, F. A. Spring, and M. J. A. Tanner. 1994. Isolation and characterization of CD47 glycoprotein: a multispanning membrane protein which is the same as integrin-associated protein (IAP) and the ovarian tumour marker OA3. Biochem. J. 304:525.
37. Brown, E. J., L. Hooper, T. Ho, and H. D. Gresham. 1990. Integrin-associated protein: a 50-kD plasma membrane antigen physically and functionally associated with integrins. J. Cell Biol. 111:2785.
38. Campell, I. G., P. S. Freemont, W. Foulkes, and J. Trowsdale. 1992. An ovarian tumor marker with homology to vaccinia virus contains an IgV-like region and multiple transmembrane domains. Cancer Res. 52:5416.
39. Reinhold, M. I., F. P. Lindberg, D. Plas, S. Reynolds, M. G. Peters, and E. J. Brown. 1995. In vivo expression of alternatively spliced forms of integrin-associated protein (CD47). J. Cell Sci. 108:3419.
40. Gresham, H. D., J. L. Goodwin, P. M. Allen, D. C. Anderson, and E. J. Brown. 1989. A novel member of the integrin receptor family mediates Arg-Gly-Asp-stimulated neutrophil phagocytosis. J. Cell Biol. 108:1935.
41. Gresham, H. D., S. P. Adams, and E. J. Brown. 1992. Ligand binding specificity of the leukocyte response integrin expressed by human neutrophils. J. Biol. Chem. 267:13895.
42. Zhou, M., and E. J. Brown. 1993. Leukocyte response integrin and integrin-associated protein act as a signal transduction unit in generation of a phagocyte respiratory burst. J. Exp. Med. 178:1165.
43. 3 and integrin-associated protein. J. Cell Biol. 130:745.
44. Senior, R. M., H. D. Gresham, G. L. Griffin, E. J. Brown, and A. E. Chung. 1992. Entactin stimulates neutrophil adhesion and chemotaxis through interactions between its Arg-Gly-Asp (RGD) domain and the leukocyte response integrin. J. Clin. Invest. 90:2251.
45. Lindberg, F. P., H. D. Gresham, M. I. Reinhold, and E. J. Brown. 1996. Integrin-associated protein immunoglobulin domain is necessary for efficient vitronectin bead binding. J. Cell Biol. 134:1313.
46. Parkos, C. A., S. P. Colgan, T. W. Liang, A. Nusrat, A. E. Bacarra, D. K. Carnes, and J. L. Madara. 1996. CD47 mediates post-adhesive events required for neutrophil migration across polarized intestinal epithelia. J. Cell Biol. 132:437.
47. Cooper, D., F. P. Lindberg, J. R. Gamble, E. J. Brown, and M. A. Vadas. 1995. Transendothelial migration of neutrophils involves integrin-associated protein (CD47). Proc. Natl. Acad. Sci. USA 92:3978.
48. Gao, A. G., F. P. Lindberg, M. B. Finn, S. D. Blystone, E. J. Brown, and W. A. Frazier. 1996. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J. Biol. Chem. 271:21.
49. Schwartz, M. A. 1993. Spreading of human endothelial cells on fibronectin or vitronectin triggers elevation of intracellular free calcium. J. Cell Biol. 120:1003.
50. Lindberg, F. P., D. C. Bullard, T. E. Caver, H. D. Gresham, A. L. Beaudet, and E. J. Brown. 1996. Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice. Science 274:795.
51. + peripheral blood monocytes. J. Immunol. 157:2001.
52. Brombacher, F., T. Schäfer, U. Weissenstein, C. Tschopp, E. Andersen, K. Bürki, and G. Baumann. 1994. IL-2 promoter-driven lacZ expression as a monitoring tool for IL-2 expression in primary T cells of transgenic mice. Int. Immunol. 6:189.
53. 2+ entry at plasma membrane in Jurkat human T-cells. Biochem. J. 319:393.
54. Rabinovitch, P. S., C. H. June, A. Grossmann, and J. A. Ledbetter. 1986. Heterogeneity among T cells in intracellular free calcium responses after mitogen stimulation with PHA or anti-CD3, simultaneous use of INDO-1 and immuno-fluorescence with flow cytometry. J. Immunol. 137:952.
55. lyn. J. Biol. Chem. 268:20725.
56. Gao, A. G., and W. A. Frazier. 1994. Identification of a receptor candidate for the carboxyl-terminal cell binding domain of thrombospondin. J. Biol. Chem. 269: 29650.
57. 3 function through integrin-associated protein. J. Cell Biol. 135:533.
58. Schwartz, M. A., E. J. Brown, and B. Fazeli. 1993. A 50 kDa integrin-associated protein is required for integrin-regulated calcium entry in endothelial cells. J. Biol. Chem. 268:19931.
59. June, C. H., J. A. Ledbetter, M. M. Gillespie, T. Lindsten, and C. B. Thompson. 1987. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell. Biol. 7:4472.
60. Imboden, J. B., A. Weiss, and J. D. Stobo. 1985. The antigen receptor on a human T cell line initiates activation by increasing cytoplasmic free calcium. J. Immunol. 134:663.
61. Weiss, A., J. Imboden, D. Shoback, and J. Stobo. 1984. Role of T3 surface molecules in human T-cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium. Proc. Natl. Acad. Sci. USA 81:4169.
62. Nisbet-Brown, E., R. K. Cheung, J. W. Lee, and E. W. Gelfand. 1985. Antigen-dependent increase in cytosolic free calcium in specific human T-lymphocyte clones. Nature 316:545.
63. Gardner, P. 1989. Calcium and T lymphocyte activation. Cell 59:15.
64. Crabtree, G. R., and N. A. Clipstone. 1994. Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu. Rev. Biochem. 63:1045.
65. lck. J. Biol. Chem. 268:27420.
66. lck) during T-cell activation. Mol. Cell. Biol. 8:4353.
67. Gollob, J. A., J. Li, E. L. Reinherz, and J. Ritz. 1995. CD2 regulates responsiveness of activated T cells to interleukin 12. J. Exp. Med. 182:721.
68. Baroja, M. L., J. L. Ceuppens, J. Van Damme, and A. Billiau. 1988. Cooperation between an anti-T cell (anti-CD28) monoclonal antibody and monocyte-produced IL-6 in the induction of T cell responsiveness to IL-2. J. Immunol. 141:1502.
69. Grabstein, K. H., J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, C. Beers, J. Richardson, M. A. Schoenborn, M. Ahdieh, L. Johnson, M. R. Alderson, J. D. Watson, D. M. Anderson, and J. G. Giri. 1994. Cloning of a T cell growth factor that interacts with the β-chain of the interleukin-2 receptor. Science 264:965.
70. McInnes, I. B., J. Al-Mughales, M. Field, B. P. Leung, F. P. Huang, R. Dixon, R. D. Sturrock, P. C. Wilkinson, and F. Y. Liew. 1996. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat. Med. 2:175.
71. + T cells by allogeneic class II-deficient B-cell lines derived from patients with bare lymphocyte syndrome. Tissue Antigens 35:136.
72. Reinhold, M. I., F. P. Lindberg, G. J. Kersh, P. M. Allen, and E. J. Brown. 1997. Costimulation of T cell activation by integrin-associated protein (CD47) is an adhesion-dependent, CD28-independent signaling pathway. J. Exp. Med. 185:1.
73. Ticchioni, M., M. Deckert, F. Mary, G. Bernard, E. J. Brown, and A. Bernard. 1997. Integrin-associated protein (CD47) is a comitogenic molecule on CD3-activated human T cells. J. Immunol. 158:677.
74. Tsao, P. W., and S. A. Mousa. 1995. Thrombospondin mediates calcium mobilization in fibroblasts via its Arg-Gly-Asp and carboxyl-terminal domains. J. Biol. Chem. 270:23747.
75. lck in activated T cells. J. Biol. Chem. 268:23275.
76. Truneh, A., F. Albert, P. Golstein, and A. M. Schmitt-Verhulst. 1985. Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature 313:318.
77. Holter, W., O. Majdic, H. Stockinger, and W. Knapp. 1985. Analysis of T cell activation with a non-mitogenic anti-CD3 antibody and the phorbol ester TPA. Clin. Exp. Immunol. 62:600.
78. Shaw, A. S., and M. L. Dustin. 1997. Making the T cell receptor go the distance: a topological view of T cell activation. Immunity 6:361.
79. Weaver, C. T., and E. R. Unanue. 1990. The costimulatory function of antigen presenting cells. Immunol. Today 11:49.
80. Nathan, C. F. 1987. Secretory products of macrophages. J. Clin. Invest. 79:319.
81. Tosato, G., and K. D. Jones. 1990. Interleukin-1 induces interleukin-6 production in peripheral blood monocytes. Blood 75:1305.
82. Jaffe, E. A., J. T. Ruggiero, and D. J. Falcone. 1985. Monocytes and macrophages synthesize and secrete thrombospondin. Blood 65:79.
83. Varani, J., L. Stoolman, T. Wang, L. Schuger, C. Flippen, M. Dame, K. J. Johnson, R. F. Todd III, U. S. Ryan, and P. A. Ward. 1991. Thrombospondin production and thrombospondin-mediated adhesion in U937 cells. Exp. Cell Res. 195:177.
84. Huber, A. R., S. Ellis, K. J. Johnson, V. M. Dixit, and J. Varani. 1992. Monocyte diapedesis through an in vitro vessel wall construct: inhibition with monoclonal antibodies to thrombospondin. J. Leukocyte Biol. 52:524.
85. Silverstein, R. L., and R. L. Nachman. 1987. Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion. J. Clin. Invest. 79: 867.
86. Killeen, N., S. G. Stuart, and D. R. Littman. 1992. Development and function of T cells in mice with a disrupted CD2 gene. EMBO J. 11:4329.